CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-06 | MICHEL GERARD J CFO and VP, Corp. Development | Grant or award · Stock Option (right to buy) | +9,303 | 9,303 | ||
| 2019-02-06 | MICHEL GERARD J CFO and VP, Corp. Development | Grant or award · Stock Option (right to buy) | +113,197 | 113,197 | ||
| 2019-02-06 | MICHEL GERARD J CFO and VP, Corp. Development | Grant or award · Restricted Stock Unit | +12,000 | 12,000 | ||
| 2019-02-06 | Colangelo Dominick President and CEO | Grant or award · Stock Option (right to buy) | +6,002 | 6,002 | ||
| 2019-02-06 | Colangelo Dominick President and CEO | Grant or award · Restricted Stock Unit | +27,750 | 27,750 | ||
| 2019-02-06 | Colangelo Dominick President and CEO | Grant or award · Stock Option (right to buy) | +303,998 | 303,998 | ||
| 2019-01-22 | ZERBE ROBERT L MD Director | Option exercise | +17,500 | $2.63 | $46K | 17,545 |
| 2019-01-22 | ZERBE ROBERT L MD Director | Option exercise · Stock Option (right to buy) | −17,500 | 0 | ||
| 2019-01-14 | MICHEL GERARD J CFO and VP, Corp. Development | Sale | −3,059 | $17.18 | $53K | 147,901 |
| 2019-01-14 | MICHEL GERARD J CFO and VP, Corp. Development | Sale | −2,633 | $17.17 | $45K | 145,268 |
| 2019-01-14 | MICHEL GERARD J CFO and VP, Corp. Development | Sale | −3,019 | $17.18 | $52K | 142,249 |
| 2019-01-02 | Wotton Paul K Director | Option exercise | +5,000 | $2.76 | $14K | 5,000 |
| 2019-01-02 | Wotton Paul K Director | Sale | −5,000 | $16.83 | $84K | 0 |
| 2019-01-02 | Wotton Paul K Director | Option exercise | +17,500 | $2.63 | $46K | 17,500 |
| 2019-01-02 | Wotton Paul K Director | Sale | −17,500 | $16.83 | $295K | 0 |
| 2019-01-02 | Wotton Paul K Director | Option exercise · Stock Option (right to buy) | −5,000 | 0 | ||
| 2019-01-02 | Wotton Paul K Director | Option exercise · Stock Option (right to buy) | −17,500 | 0 | ||
| 2018-12-10 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise | +10,000 | $1.95 | $20K | 160,960 |
| 2018-12-10 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise | +5,625 | $2.65 | $15K | 166,585 |
| 2018-12-10 | MICHEL GERARD J CFO and VP, Corp. Development | Sale | −10,000 | $16.81 | $168K | 156,585 |
Page 61 of 75 · 1,497 trades